Month: November 2021

Nov 15 2021

Uncategorized

Oklahomans with mood disorders like depression are at high risk for COVID-19, CDC says

by Clinical Editor

No Comments

More Oklahomans could be at high risk for COVID-19 than they realize. Without much fanfare, the Centers for Disease Control and Prevention last month added mood disorders — including depression,...

Nov 15 2021

Uncategorized

COVID Doesn’t Dampen LAI Antipsychotic Prescribing in Schizophrenia

by Clinical Editor

No Comments

Of the prescribers who responded to the survey, 59.8% said that they did not see any increases or decreases in their 2020 prescribing trends. Among this majority, most concerns about...

Nov 14 2021

Uncategorized

Schizophrenia: A Difference of Kind

by Clinical Editor

No Comments

I wish here to provide a brief refutation of this notion and an examination of schizophrenia as a pathology that differs in kind from normal human experience. For these and...

Nov 14 2021

Uncategorized

Schizophrenia drug landscape: a stagnant field on the cusp of change?

by Clinical Editor

No Comments

Several pipeline therapies could shake up the schizophrenia field, but their road through development is unlikely to be an easy path. Most new drugs in schizophrenia have relied on similar...

Nov 14 2021

Uncategorized

Schizophrenia burden totaled more than $340 billion in 2019

by Clinical Editor

No Comments

Schizophrenia’s approximate societal burden was $341.5 billion in the U.S. in 2019, according to study results presented at Psych Congress.Adjusted for inflation, this represented a 99.8% increase in …

Nov 14 2021

Uncategorized

Cigarette Smoking and Life Expectancy in Schizophrenia

by Clinical Editor

No Comments

Put out your cigarette. Researchers performed a cohort study of the impact of cigarette smoking on life expectancy in schizophrenia, schizoaffective disorder, and bipolar disorder.

Nov 14 2021

Uncategorized

Antipsychotic Patch Quiets Schizophrenia-Related Hostility

by Clinical Editor

No Comments

The antipsychotic “patch” effectively reduced hostility among patients with schizophrenia, a researcher reported. In a post-hoc analysis of a phase III trial, once-daily asenapine transdermal system …

Nov 13 2021

Uncategorized

Signs of Schizophrenia in Teens – PsychCentral.com

by Clinical Editor

No Comments

Signs of Schizophrenia in Teens  PsychCentral.com

Nov 13 2021

Uncategorized

Schizophrenia: A Difference of Kind

by Clinical Editor

No Comments

I wish here to provide a brief refutation of this notion and an examination of schizophrenia as a pathology that differs in kind from normal human experience. For these and...

Nov 13 2021

Uncategorized

Schizophrenia drug landscape: a stagnant field on the cusp of change?

by Clinical Editor

No Comments

Several pipeline therapies could shake up the schizophrenia field, but their road through development is unlikely to be an easy path. Most new drugs in schizophrenia have relied on similar...